Menu

ABSTRACTS

O.09 Geriatric assessment (GA)- guided interventions in older patients (pts) with cancer

BJMO - 2017, issue 3, february 2017

L. Decoster MD, PhD, C. Kenis RN, PhD, J. Flamaing , P.R. Debruyne , I. De Groof , C. Focan MD, PhD, F. Cornélis MD, V. Verschaeve MD, K. Vanoverbeke , Y. Libert , S. Luce , N. Nols , H. van den Bulck , J.C. Goeminne MD, K. Geboers , J.P. Lobelle , M. Lycke , K. Milisen PhD, H. Wildiers MD, PhD, A. Baitar

Read more

O.10 USP13 as a novel co-target for EGFR targeted therapies in EGFR mutant non-small cell lung cancer

BJMO - 2017, issue 3, february 2017

P. Giron PhD, C. Eggermont , E. Teugels PhD, G. Gutierrez , J. De Grève MD, PhD

Read more

P.01 Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer (NSCLC) cells

BJMO - 2017, issue 3, february 2017

A. Noor , U.A. Ijeoma , P. Kronenberger , E. Teugels PhD, J. De Grève MD, PhD

Read more

P.02 Polymorphisms in the Von Hippel Lindau gene are associated with poor overall survival in metastatic clear-cell renal cell carcinoma patients treated with VEGFR tyrosine kinase inhibitors

BJMO - 2017, issue 3, february 2017

A. Verbiest MD, PhD, J. Zucman-Rossi , D. Lambrechts PhD, B. Beuselinck MD, PhD

Read more

P.03 Selective internal radiotherapy: a 5-year single-center experience

BJMO - 2017, issue 3, february 2017

T. Van den Mooter MD, S. Van Hecke , I. Huyghe , T. Chapelle , M. Peeters MD, PhD

Read more

P.04 Osteonecrosis of the Jaw Incidence in Patients Treated Sequentially with Bisphosphonates and Denosumab

BJMO - 2017, issue 3, february 2017

T. Loyson , T. Van Cann , C. Politis , B. Beuselinck MD, PhD

Read more

P.05 Incidence of osteonecrosis of the jaw in patients both treated with bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

BJMO - 2017, issue 3, february 2017

T. Van Cann , T. Loyson , C. Politis , P. Debruyne MD, PhD, B. Beuselinck MD, PhD

Read more
Top